Frankfurt - Delayed Quote EUR
Gilead Sciences, Inc. (GIS.F)
93.51
+0.68
+(0.73%)
At close: April 24 at 8:04:42 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 15 | 15 | 25 | 23 |
Avg. Estimate | 6.97B | 7.4B | 28.73B | 29.85B |
Low Estimate | 6.79B | 7.24B | 28.34B | 28.7B |
High Estimate | 7.27B | 7.58B | 29.37B | 31.88B |
Year Ago Sales | 6.95B | 7.54B | 28.75B | 28.73B |
Sales Growth (year/est) | 0.18% | -1.90% | -0.09% | 3.90% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
GIS.F | -- | -- | -- | -- |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
Maintains | JP Morgan: Overweight to Overweight | 3/27/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 3/11/2025 |
Maintains | B of A Securities: Buy to Buy | 3/5/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 3/5/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 3/4/2025 |
Upgrade | Deutsche Bank: Hold to Buy | 2/18/2025 |